Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples